drugset
drugset / Trial / NCT03249402

A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants

NCT03249402 ↗

Phase 1 Completed 24 enrolled Janssen-Cilag International NV
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the effect of multiple 40 milligram (mg) doses of JNJ-42847922 on the steady state pharmacokinetics (PK) of multiple doses of a combination oral contraceptive (OC) containing ethinyl estradiol (EE) and levonorgestrel (LN) in healthy female adult partcipants.

Timeline

Start
2017-08-14
Primary completion
2017-11-24
Completion
2017-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 0.15 mg Oral
Subject Seltorexant Small molecule 40 mg Oral
Subject ethinyl estradiol Small molecule 0.03 mg Oral

Indications

No indication recorded.